Clinical trial

Immune Tumor Stroma Factors and Pathologic Complete Response After Neoadjuvant Chemotherapy in Early Breast Cancer

NCT07407244

Study summary

ClinicalTrials.gov

Immune Tumor Stroma Factors and Pathologic Complete Response After Neoadjuvant Chemotherapy in Early Breast Cancer

Design: INTERVENTIONAL · Status: ACTIVE NOT RECRUITING · Phase: NA

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Unmapped registry intervention Neoadjuvant Chemotherapy Find medicine records · Find other trials using this name

StatusACTIVE_NOT_RECRUITING

Study typeINTERVENTIONAL

Start date2017-03-01

PhaseNA

Conditions

Breast Cancerverified · MONDO: breast cancer

Interventions

Neoadjuvant ChemotherapyDRUG

Sponsors & collaborators

Institute of Oncology Ljubljanalead sponsor

Mapped research locations

LjubljanaSlovenia1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07407244 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.